Human Amyloid Beta Precursor Protein Binding Protein A2 (APBA2) Protein

Product specifications

Proteins and Peptides

Amyloid Beta Precursor Protein Binding Protein A2 (APBA2)

E. coli

Human

Unconjugated

Molecular Weight: Calculated MW: 32.5 kDa
Concentration: Prior to lyophilization: 200 µg/ml
Sequence Fragment: Tyr459-Asn722
Tag: N-terminal His tag

Recombinant

> 95%

10 µg

50 µg

100 µg

200 µg

500 µg

Lyophilized To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.

WB, SDS-PAGE

Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.

Shipped within 5-7 working days.

Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.

No

Q99767

APBA2, D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11-BETA, X11L, amyloid beta precursor protein binding family A member 2

Protein APBA2

RUO

This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

APBA2 is a member of the X11 protein family, known for its role in interacting with the amyloid-beta precursor protein (APP). APBA2 is predominantly expressed in neuronal tissues, where it contributes to the regulation of APP trafficking, processing, and stabilization. This protein is involved in modulating amyloid-beta peptide production, a critical factor in Alzheimer’s disease pathology. By binding APP through its phosphotyrosine-binding (PTB) domain, APBA2 helps reduce the formation of amyloid-beta aggregates, which are the hallmark of neurodegeneration. Apart from its role in APP metabolism, APBA2 has been shown to participate in intracellular trafficking, synaptic vesicle function, and neuronal signal transduction pathways. Dysfunction of APBA2 may lead to abnormal APP processing, contributing to increased amyloid-beta deposition, oxidative stress, and neurotoxicity. Studies indicate that APBA2 is crucial for maintaining synaptic plasticity and cognitive functions, and its dysregulation may play a role in Alzheimer’s disease and other neurodegenerative disorders. As a molecular chaperone and stabilizer of APP, APBA2 is being explored as a potential therapeutic target to reduce amyloid plaque burden and preserve neuronal function in neurodegenerative diseases.

Related Products

Human Amyloid-beta Precursor Protein (APP) CLIA Kit

Human Beta-Amyloid Precursor Protein (APP) Chemiluminescent Immunoassay (CLIA) Kit is a Chemiluminescent Immunoassay (CLIA) kit against Beta-Amyloid Precursor Protein (APP).

Ver Producto

beta Amyloid / A4 Protein Precusor (APP)

β-Amyloid/A4 Protein Precusor (APP) (319-335) is a peptide.

Ver Producto

Dog Amyloid-beta Precursor Protein (APP) ELISA Kit

Dog Amyloid-beta Precursor Protein (APP) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Dog Amyloid beta A4 protein concentrations in serum, plasma, tissue homogenates, cell lysates and other biological fluids.

Ver Producto